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Abstract
Background: DrTx(1-42) (a carboxyl-terminally truncated version of drosotoxin) is a potent and selective blocker of
tetrodotoxin-resistant (TTX-R) Na
+ channels in rat dorsal root ganglion neurons with analgesic activity. This purpose is to
identify key amino acids which are responsible for both blocking and analgesic effects of DrTx(1-42).
Methods: On the basis of previous study, we designed five mutants of DrTx(1-42) (delN, D8A, D8K, G9A, and G9R) in the
amino-terminal turn (N-turn) region, a proposed functional region located in the amino-terminus of the molecule. All these
mutants were expressed in E.coli and purified by RP-HPLC. Electrophysiological properties of these analogues were
examined by whole-cell patch-clamp recordings and their antinociceptive effects were investigated by the formalin test and
acetic acid induced writhing test.
Results: All the mutants except for G9A possess a similar secondary structure to that of DrTx(1-42), as identified by circular
dichroism analysis. Three mutants (delN, D8A and G9A) were found almost inactive to TTX-R Na
+ channels, whereas D8K
retains similar activity and G9R showed decreased potency when compared with the wild-type molecule. Consistent with
the electrophysiological observations, D8K and G9R exhibited antinociceptive effects in the second phase (inflammatory
pain) of the formalin test and the acetic acid induced writhing test, while delN, D8A and G9A lack such effects.
Conclusions: Our results show that the N-turn is closely related to function of DrTx(1-42). The mutant (D8A) as a control
peptide further reveals that a charged residue at site 8 of the N-terminus is important for channel blockade and analgesic
activity. This study indicates that blocking of voltage-gated TTX-R Na
+ channel in DRG neurons contributes to analgesic
effect in rat inflammatory pain. Structural and functional data described here offers support for the development of novel
analgesic drugs through targeting TTX-R Na
+ channels.
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Introduction
Inflammatory pain, caused by tissue injury or inflammation, is a
serious medical problem worldwide and especially difficult to treat
[1]. Voltage-gated Na
+ channel (Nav) blockers have been clinically
validated as treatments for inflammatory pain. However, non-
selective inhibitors of Navs generally have dose-limiting central
nervous system and cardiovascular side effects, which prevent their
use in long term therapy [2,3]. Previous studies have showed that
the deletion of TTX-R Nav genes or pharmacological inhibition of
their functions can markedly reduce some inflammatory pains
[4,5], recent study also validated that antisense-mediated knock-
down of Nav1.8 -TTX-R sodium channel generated inhibitory
effects on Complete Freund’s Adjuvant-Induced inflammatory
pain in rat [6], supporting the importance of TTX-R sodium
channels as new targets to develop therapeutic agents for
inflammatory pain.
Navs are large transmembrane proteins that mediate the rising
phase of the action potential in excitable cells. In mammals, there
are nine Nav subtypes (Nav1.1-Nav1.9) identified, all having
distinct tissue distributions and biophysical properties [7]. Based
on their sensitivity to TTX, these nine Navs can be classified as
either TTX-sensitive (TTX-S) (eg, Nav1.1-Nav1.4, Nav1.6 and
Nav1.7) or TTX-R (eg, Nav1.5, Nav1.8 and Nav1.9) [8]. Two
remarkable TTX-R channels , Nav1.8 and Nav1.9 are predom-
inantly expressed in nociceptive neurons in the dorsal root
ganglion [2].
Because of key roles of TTX-R Na
+ channels in inflammatory
pain sensation, it is extremely desirable to search for specific
blocker of these channels as drug leads. Animal venoms have been
proved to be a rich source of peptide toxins that function as
modulators or blockers of Navs [9,10]. However, the majority of
these toxins were reported to only affect TTX-S Na
+ channels,
and the only one naturally-occurring blocker (Conotoxin mm-
SIIIA) selectively targeting mammalian TTX-R sodium channels
was identified from Conus striatus, 3 mMm m-SIIIA could almost
completely inhibit TTX-R Na
+ currents [11]. In addition, two
conotoxins (mO-MrVIA and mO-MrVIB) were found to preferen-
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5tially block mammalian TTX-R over TTX-S channels, and their
respective IC50s of inhibition to TTX-R currents were 82.8 and
98 nM. Accordingly, mO-MrVIB reduced both inflammatory and
neuropathic pain [5].
Recently, we reported an engineered chimeric peptide droso-
toxin, which was achieved by using drosomycin (Drosophila
antifungal defensin) to substitute the structural core of BmKITc,
a weak depressant toxin acting on both insect and mammalian
Na
+ channels. Our data indicated that recombinant drosotoxin
possessed strong potential to selectively block TTX-R Na
+
currents in rat DRG neurons with a 50% inhibitory concentration
(IC50) of 2.6060.50 mM [12]. During production of drosotoxin,
we unexpectedly achieved a C-terminally truncated drosotoxin
DrTx(1-42), which also displayed high inhibitory effect on rat
TTX-R Na
+ channels with an IC50 value of 1.7460.07 mM.
Furthermore, we found that DrTx(1-42) was significantly able to
reduce inflammatory pain in the formalin test [13].
Given promising therapeutic potential of DrTx(1-42), a logical
next step is to understand its structure-function relationship for
guiding further molecular design. Here we aim at previously
proposed functional region of this peptide to highlight key amino
acids sites essential for blockade as well as analgesic effect by using
mutational experiments combined with electrophysiological and
antinociceptive assays. Our results highlight the functional
importance of a charged residue at the N-turn of DrTx(1-42).
Materials and Methods
Ethics statement
All experimental protocols were reviewed and approved by the
Animal Care and Use Committee of Institute of Zoology, the
Chinese Academy of Sciences. The institute does not issue a
number to any animal study, but each study requires the permit to
use animals from the ethical committee. The animal facility must
be licensed by the experimental animal committee of Beijing, and
all staff, fellows and students must receive appropriate training
before performing animal studies.
Materials
ATP, T4 DNA ligase and ExTaq polymerase were obtained
from Takara (Dalian, China); Pfu polymerase and polynucleotide
kinase were respectively purchased from newProbe (Beijing,
China) and TOYOBO (Osaka, Japan); Glutathione Sepharose
4B beads was purchased from GE Healthcare (Shanghai, China);
Fetal bovine serum (FBS) was purchased from Sijiqing Biotech Co.
Ltd. (Hangzhou, China); Enterokinase (EK) was obtained from
Sinobio Biotech Co. Ltd. (Shanghai, China); tetrodotoxin (TTX),
trypsin (type III), collagenase (IA), trypsin inhibitor (type II-S),
Dulbecco’ s modified Eagle’ s medium (DMEM), tetraethylam-
monium chloride (TEA-Cl), D-glucose, 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES), CsF, CsOH, CsCl, NaCl,
KCl, MgCl2, CaCl2, and NaOH were purchased from Sigma -
Aldrich (Shanghai, China). All these reagents were of analytical
grade.
Animals
All animals were purchased from Experimental Animal Center,
Academy of Military Medical Sciences. Animals were housed in a
temperature controlled room (22–25uC) with water and food
available ad libitum, and on a 12 h light/dark cycle.
Site-directed mutagenesis
All primers used in this study were synthesized by SBS
Genetech (Beijing, China) (Table 1). Inverse PCR, as previously
described [14], was used to generate DrTx(1-42) (GenBank
accession number GQ422754) and its mutants by using the
recombinant plasmid pGEX-6P-1-drosotoxin and pGEX-6P-1-
DrTx(1-42) as templates [12]. Phosphorylation of the 59-end of
primers was performed using polynucleotide kinase and ATP.
PCR reaction conditions were as follows: 30 cycles of 45 s at 94uC
and 8 min at 68uC with ExTaq DNA polymerase. Subsequently,
linear PCR products were circularized by T4 DNA ligase after end
polishing using Pfu polymerase. Circularized products were
transformed into E. coli DH5a competent cells. Positive clones
were confirmed by DNA sequencing.
Expression, purification and identification of
recombinant products
Expression and purification of DrTx(1-42) and its mutants were
performed according to the methods previously described [15]. In
brief, the expression of recombinant DrTx(1-42) and its mutants in
Table 1. Primers used in this study.
DrTx(1-42) and Mutants Primer Name Sequence
DrTx(1-42) DrTx(1-42)-FP 59-TAAGTCGACTCGAGCGGCCGCATCGTG-39
DrTx(1-42)-RP 59-CTTCAGACTGGGGCTGCAGTGGCCACT-39
D8K D8K-FP 59-AAGGGATGCTACAAGGGTCCCTGTGCCGTC-39
D8K-RP 59-ACTTCTTCCGGACAGGCCGTCCTTGTCATC-39
G9R G9R-FP 59-AGATGCTACAAGGGTCCCTGTGCCGTCTG-39
G9R-RP 59-GTCACTTCTTCCGGACAGGCCGTCCTTG-39
D8A D8A-FP 59-GCCGGATGCTACAAGGGTCCCTGTGCCGTC-39
D8A-RP 59-ACTTCTTCCGGACAGGCCGTCCTTGTCATC-39
G9A G9A-FP 59-GCCTGCTACAAGGGTCCCTGTGCCGTCTG-39
G9A-RP 59-GTCACTTCTTCCGGACAGGCCGTCCTTG-39
del N delN-FP 59-TACAAGGGTCCCTGTGCCGTCTGGGAC-39
delN-RP 59-TCTTCCGGACAGGCCGTCCTTGTCATC-39
Note: Mutated nucleotides are underlined once. All primers listed here were synthesized by SBS Genetech (Beijing, China).
doi:10.1371/journal.pone.0031830.t001
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thiogalactopyranoside (IPTG) and fusion protein was acquired in
supernatant after sonication, followed by affinity chromatography
with Glutathione–Sepharose 4B beads. Then the fusion protein
was cleaved with enterokinase at 4uC overnight. The released
protein samples were separated by RP-HPLC on C18 column
(Agilent Zorbax 300SB, 4.6 mm6150 mm, 5 mm) using a linear
gradient of 0–60% acetonitrile in 0.1% trifluoroacetic acid (TFA)
in water (v/v) within 40 min with a flow rate of 1 ml/min, with
detection at 225 nm. Peptides were eluted as major peaks at 28–
30% acetonitrile. Molecular weights (MWs) of purified products
were determined by matrix-assisted laser desorption ionization
time-of-flight (MALDI-TOF) mass spectra on a Kratos PC Axima
CFR plus (Shimadzu Co. Ltd, Kyoto).
Circular dichroism analysis
The secondary structures of purified DrTx(1-42) and its mutants
were measured by circular dichroism (CD) spectroscopy. All the
peptides were dissolved in water at a concentration of 0.3 mg/ml.
Measurements were carried out in the UV range of 260–190 nm
at 25uC using a quartz cell of 1.0 mm in thickness on a JASCO J-
720 spectropolarimeter. For each peptide, spectra were collected
from 3 separate recordings and averaged at 0.5 nm intervals with
a scan rate of 50 nm/min.
Isolation of DRG neurons
DRG neurons were obtained as described in Xiao et al. [16].
Briefly, Adult male Sprague - Dawley rats (4 weeks old) were
killed by decapitation without anesthetization, the DRGs were
removed quickly from the spinal cord, and after having been cut
into as small tissues as possible, they were transferred into
DMEM containing trypsin (0.15 mg/ml, type III), collagenase
(0.4 mg/ml, type IA) to incubate at 34uC for 20–30 min.
Trypsin inhibitor (0.25 mg/ml, type II-S) was added to
terminate the reaction. After centrifugation and resuspension,
cells were plated on 13 mm diameter glass cover slips which had
been precoated with poly-L-lysine (100 mg/ml, Sigma) and kept
at 37uC in a humidified incubator gassed with 5% CO2 in air for
30–60 min. And then 2 ml DMEM containing 10% heat-
inactivated fetal calf serum and 100 u/ml penicillin–streptomy-
cin were added into the dish. Cells were cultured for 2–4 h
before patch-clamping.
Whole-cell Patch-Clamp Recordings
The Whole-cell configuration of patch-clamp technique was
used to record Na
+ currents in DRG neurons [16]. For Na
+
current recordings, the pipette internal solution contained (in
mM): CsF 135, NaCl 10 and HEPES 5, adjusted to pH 7.2 with
CsOH. The external bathing solution contained (in mM): NaCl
30, KCl 5, CsCl 5, D-glucose 25, MgCl2 1, CaCl2 1.8, HEPES 5
and TEA-Cl 90, pH 7.4 with NaOH. TTX-R Na
+ currents
(TTX-R INa) were recorded from small DRG neurons (#25 mm
diameter) in the presence of 300 nM TTX. Micropipettes were
pulled from borosilicate glass capillary tubing by P-97(Sutter
Instrument Co., Novato, CA, USA), the resistances of micropi-
pettes were 3–6 MV after filled with internal solution. Na
+ current
traces were evoked by 50 ms depolarization from a holding
potential of 280 mV to 210 mV. Currents were measured using
an AxoClamp 2B amplifier (Axon Inc.) and DIGIDATA 1322A
(Axon Inc.). Series resistance was routinely compensated by 70–
80%. Capacitive and leakage currents were digitally subtracted by
using a P/4 pulse protocol. Pulse stimulation and data acquisition
were controlled by Clampex 9.0 software (Axon Inc.). Data are
expressed as mean 6 standard errors (SEM), the IC50 of mutant
was calculated according to the Hill equation: I=Imax/[1+(IC50/
[A])
H], where Imax is the control current to the peak, I is the
remained current after adding polypeptide, A is concentration ,
and H is the Hill coefficient.
Formalin Test
Healthy male ICR (imprinting control region) mice, weighing
18–22 g, were used in this study. The procedure used here was
similar to the method described by Gomes et al [17]. Briefly,
Figure 2. Circular dichroism spectra of DrTx(1-42) and its
mutants. The measurement was carried out in the UV range of 260–
190 nm at 25uC in water on a JASCO J-720 spectropolarimeter by
averaging three scans. The protein concentration was 0.3 mg/ml.
doi:10.1371/journal.pone.0031830.g002
Figure 1. Sequence alignment of DrTx(1-42) and its mutants. The N-turn region derived from BmKITc is shadowed in yellow. Mutated sites are
indicated in red.
doi:10.1371/journal.pone.0031830.g001
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the ventral surface of the mice’s right hind paws. Immediately after
formalin injection, animals were individually placed in a glass
observation chamber with a transparent floor. The summation of
time (in seconds) that animals spent licking the injected paws was
recorded from 0 to 5 min (neurogenic phase, corresponding to a
direct chemical stimulation of nociceptors) and from 15 to 30 min
(inflammatory phase, involving release of inflammatory mediators)
after injection of formalin. Mice were pre-treated (i.v.) with
peptides (0.1, 0.5 and 1 mg/kg) or vehicle (saline), 30 min before
injection of formalin. In the positive control group, animals were
pre-treated with indomethacin (10 mg/kg, i.v.). Results are
expressed as mean 6 standard errors (SEM) ,and analyzed as
follows: Student Newman-Keuls post hoc test, one-way analysis of
variance (ANOVA). A value of p,0.05 was considered to be
statistically significant.
Figure 3. Effects of DrTx(1-42) and its mutants on TTX-R Na
+ currents in rat DRG neurons (#25 microm diameter). A Representative
current traces of TTX-R Na
+ currents blocked by DrTx(1-42) and its mutants. TTX-R INa was evoked by 50 ms depolarization from a holding potential of
280 mV to 210 mV. B The concentration-dependent inhibition of TTX-R Na
+ channels by DrTx(1-42) and its mutants. Each point is the mean 6 SEM
for n=5–8. These data points (DrTx(1-42), D8K and G9R) were fitted according to the Hill equation, the yielded IC50 values as follows: DrTx(1-42):
4.0560.35 mM; D8K: 2.2560.15 mM; G9R: 18.1961.02 mM. NOTE-Recombinant DrTx(1-42) prepared in this study possesses comparable potency on
TTX-R INa with that previously reported (Zhu et al., 2011).
doi:10.1371/journal.pone.0031830.g003
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Healthy male ICR (imprinting control region) mice, weighing
18–22 g, were used in this study. Writhing test was performed as
visceral inflammatory pain model [18]. Abdominal writhing is a
model of visceral pain and nociceptive stimulus was induced with
0.6% acetic acid solution intraperitoneally injected to mice
(0.1 ml/10 g of body weight). The number of writhes, which
consists of abdominal muscle contractions and hind paw
extension, were recorded for 15 min starting 5 min after i.p.
injection. Each experimental group was formed by 8 mice.
Animals were pre-treated (i.v.) with peptides (0.1, 0.5 and 1 mg/
kg) or vehicle (saline), 30 min before administration of acetic acid.
In the positive control groups, animals were pre-treated with
indomethacin (10 mg/kg, i.v.). Results are expressed as mean 6
standard errors (SEM) ,and statistically analyzed as same as above
formalin test.
Results
Design strategy of mutation
Our previous reported data indicated that both drosotoxin and
DrTx(1-42) were potent blocker to TTX-R channels, and both
encompass the N-turn sequence grafted from BmKITc, accord-
ingly we assume that this sequence motif could play a crucial role
in the interaction with TTX-R Na
+ channels. To test this
assumption, firstly we designed an N-turn-deleted mutant (named
delN) and found that delN almost had no inhibitory effects on
TTX-R INa at 30 mM. Because of its similar structural feature to
DrTx(1-42), the absence of activity provides direct evidence in
favor of the importance of the N-turn in the interaction with TTX-
RN a
+ channels. Subsequently to identify which residues in the N-
turn are possibly involved in the interaction with the channels, we
further carried out a series of site-directed mutagenesis of the N-
turn (D8A, D8K, G9A and G9R) (Fig. 1) and evaluated their
electrophysiological and antinociceptive function.
Recombinant production of DrTx(1-42) and its mutants
Expression, purification and identification of DrTx(1-42) and its
mutants were presented in Fig. S1, Fig. S2, Fig. S3). The MWs
of all HPLC-purified mutants were confirmed by MALDI-TOF,
which show that the MWs of all the recombinant products are
close to their theoretical MWs (Table S1 and Fig. S4, provided
as electronic supplementary material). The CD spectra of these
products were shown in Fig. 2, from which it can be seen that
except for G9A, the spectra of all other mutants were found to be
similar to that of DrTx(1-42), indicating no major secondary
structure alterations in these mutants. However, the CD spectrum
of G9A indicates that it is more helical compared to the other
proteins.
TTX-R Na
+ channel blocking activities of DrTx(1-42)
mutants
The blocking activities of these mutants were tested on TTX-R
Na
+ channels. The representative current traces of these mutants
were showed in Fig. 3A. The mutant D8K significantly inhibited
TTX-R INa at 2.5 mM concentration (n=8), G9R inhibited about
60% TTX-R INa at 20 mM concentration (n=5), whereas other
mutants (D8A, G9A and delN) even at the concentration up to
30 mM had almost no effect on TTX-R INa (n=8). Furthermore
we also found blockade to TTX-R channels with DrTx(1-42),
D8K and G9R was reversible since TTX-R INa could be
recovered after washout (data shown in Fig. S5). As illustrated in
Fig. 3B, when compared with DrTx(1-42), the mutant D8K
showed almost the same activity (IC50=2.2560.15 mM, n=8),
while G9R showed decreased activity (IC50=18.1961.02 mM,
n=5). Effect of 2.5 mM D8K on the current - voltage (I–V) curves
of TTX-R currents are illustrated in Fig. 4. From the curve, the
inhibition to TTX-R currents was observed by 2.5 mM D8K, and
the current inhibition was not associated with a change of the
shape of the I–V relationship. Furthermore no shift in the
membrane reversal potential of the TTX-R channels was
observed, implying that D8K does not change the ion selectivity
of the channels. The I–V curve indicates that inhibition effect of
D8K on TTX-R sodium currents is the same as that of DrTx(1-
42) and DrTx [12,13].
Analgesic effects of the DrTx(1-42) mutants in the
formalin test
Given blockers targeting TTX-R Na
+ channels have been
characterized as effective antinociceptive agents [19], we evaluated
the relationship of channel-blockade and antinociceptive activity
of the DrTx(1-42) mutants in the formalin test in mice. During the
first phase (neurogenic phase) of the formalin test, the adminis-
tration of D8K and G9R only with maximal dose (1 mg/kg each)
caused slight reduction in licking time of mice compared to the
saline control (p,0.05) (Fig. 5A). In the second phase (inflam-
matory phase) of the formalin test, we found that the treatment by
D8K and G9R (0.1, 0.5 and 1 mg/kg) significantly reduced licking
time (p,0.01). The administration of mutants D8K and G9R with
maximal dose (1 mg/kg) resulted in a significant inhibition of
licking time by 50.17% and 39.62% respectively, which is
comparable with positive control indomethacin (10 mg/kg).
Indomethacin is a well-known non-steroidal anti-inflammatory
drug acting through the inhibition of the inflammatory mediators
of the acute phase of inflammation and is used frequently
worldwide for the alleviation of pain despite their capacity to
cause adverse gastrointestinal side effects [20]. In contrast,
administration of mutants D8A, G9A and delN with maximal
Figure 4. The current - voltage (I–V) relationship of D8K on
TTX-R currents. I–V relationships of TTX-R currents before (filled
circles) and after (open circles) the treatment of 2.5 mMD 8 K ,
respectively. Cells were held at 280 mV, and TTX-R currents were
elicited by 50 ms depolarizing steps to various potentials ranging from
280 mV to +40 mV in 10 mV increments. Only D8K is presented here
for example.
doi:10.1371/journal.pone.0031830.g004
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licking time (Fig. 5B).
Analgesic effects of the DrTx(1-42) mutants in the
writhing test
Subsequently, we used another pain model by intraperitoneal
injection of acetic acid that causes visceral inflammatory pain due
to liberation of several mediators, such as histamine, serotonin,
bradykinin, cytokines, and eicosanoids [21,22]. These inflamma-
tory mediators are able to increase vascular permeability, as well as
to reduce the threshold of the nociception and to stimulate the
nervous terminal of nociceptive fibers [23].The administration of
mutants D8K and G9R at three doses (0.1, 0.5 and 1 mg/kg)
caused a significant reduction in the writhing number induced by
acetic acid in a dose-dependant manner (Fig. 6), in which both
with maximal dose (1 mg/kg) resulted in the inhibition of writhing
by 69.27% and 56.42%, respectively, comparable with positive
control indomethacin (10 mg/kg). In contrast, the administration
of mutants D8A, G9A and delN with maximal dose (1 mg/kg), no
significant analgesic effects were found (Fig. 6). Animal behavioral
observations indicate that D8K and G9R have obvious antinoci-
ceptive effects during the inflammatory phase of the formalin and
the acetic acid induced visceral inflammatory pain model and thus
support that DrTx(1-42), D8K and G9R are ideal candidates of
analgesics. Blocking effects of these mutants on TTX-R INa in rat
DRG neurons are consistent with their antinociceptive effects in
animal tests obtained (Table 2). Their consistency further
demonstrates that the inhibition of TTX-R Na
+ channels will be
a promising strategy to develop new analgesics.
Discussion
DrTx(1-42) is a potent and selective blocker of TTX-R Na
+
channels in DRG neurons with analgesic activity [13]. The present
study is to identify key amino acids which are responsible for both
blocking and analgesic effects of DrTx(1-42). On the basis of
previous study [13], we firstly constructed a delN mutant, which
had a similar CD spectrum to that of DrTx(1-42), but lose
inhibitory effect on TTX-R INa and analgesic activity. These
observations indicate that the N-turn is important for the function
of DrTx(1-42).
Subsequently, we further carried out a series of site-directed
mutagenesis of the N-turn (D8A, D8K, G9A and G9R) and found
when Asp8 in the N-turn was substituted with an Ala, the blockade
activity of this peptide on TTX-R Na
+ channel nearly completely
lose. However, when this acidic residue was reversed into a Lys, the
mutant D8K retained almost the same blockade activity compared
with DrTx(1-42). Based on structural similarity between these two
mutants and DrTx(1-42), it appears that a charged group at site 8 (a
positive or negative charge) is crucial for blocking of TTX-R Na
+
channels. Furthermore it also indicates that D8 binds to TTX-R
Na
+ channels by a non-electrostatic interaction mode. Given these
Figure 6. Effects of DrTx(1-42) and its mutants on acetic acid-
induced writhing test in mice. Data are reported as mean 6 SEM for
n=8 per group. One-way ANOVA followed by Student Newman Keuls
post hoc test. *: P,0.05; **: P,0.01 compared to vehicle-treated group
(saline).
doi:10.1371/journal.pone.0031830.g006
Figure 5. Effects of DTX(1-42) and its mutants on the time
spent licking during the neurogenic (A) and inflammatory (B)
phases of the formalin test in mice. The y-axis represents the time
spent licking in sec during neurogenic and inflammatory phases. Data
are reported as mean 6 SEM for n=8 per group. One-way ANOVA
followed by Student Newman Keuls post hoc test. *: P,0.05, **: P,0.01
compared to vehicle-treated group (saline).
doi:10.1371/journal.pone.0031830.g005
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group on the side chain of site 8 possibly aids its positioning to favor
an orientation in the solvent. Romeo et al reported that the mutant
V6K at N-terminal segment of discrepin increased the blocking
effect of potassium channel [24]. Our lab has previously found that
the mutants D1A, R6A and K8A of drosomycin markedly
decreased the antifungal activity of drosomycin [25]. Although
these three peptides are by no means comparable in mechanism of
action, it is interesting to observe a strategic commonality which
hydrophilic charged group on the side chain at N-terminal is crucial
to their activities. From the results of CD spectra, substitution of
Gly9 by an Ala resulted in generating a more helical structure,
which is different from the other peptides. Compared to the other
peptide, the structure of G9A is more helical, but it completely
abolished inhibition activity. But for the mutant G9R without
structural change, an even lower activity was observed. It indicates
that the structural change in G9A has a larger effect on function
than just substituting the residue without structural change.
Structure and activity analysis of G9A validates that more tight
structure is not often associated with higher activity, as previously
observed in an insect defensin [26].
Conclusion
This study indicates that blocking of voltage-gated TTX-R Na
+
channel in DRG neurons contributes to analgesic effect in rat
inflammatory pain. In addition, it is clear that a charged residue in
the N-turn of DrTx(1-42) could play a key role in such blockade.
Structural and functional analysis of the analgesic DrTx(1-42)
provides molecular basis for further design of new analgesics for
pain treatment.
Supporting Information
Figure S1 Expression vector map showing the position of
DrTx(1-42).
(DOC)
Figure S2 Inverse PCR-mediated strategy to construct expres-
sion vectors, in which pGEX-6P-1-drosotoxin was initially used as
template to generate the DrTx(1-42) expression vector which was
further used to construct all the five mutants, including delN
(SDGC deleted), D8K, D8A, G9A, and G9R.
(DOC)
Figure S3 RP-HPLC showing the purification of DrTx(1-42).
Elution was carried out using a linear gradient of 0–60%
acetonitrile in 0.1% trifluoroacetic acid in water (v/v) within
40 min with a flow rate of 1 ml/min. The re-purification is
provided in inset.
(DOC)
Figure S4 Determination of molecular weights of HPLC-
purified DrTx(1-42) and its mutants by MALDI-TOF.
(DOC)
Figure S5 Time - effect curves of mutants on TTX-R sodium
peak currents. The channels were depolarized to 210 mV from a
holding potential of 280 mV. A. 8 mM DrTx(1-42); B. 5 mM
D8K; C. 30 mM G9R.
(DOC)
Table S1 Molecular weights of DrTx(1-42) and its mutants.
(DOC)
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